LEADER 02808oam  2200577I  450 
001 9910779280203321
005 20230802005159.0
010   $a0-429-16725-3
010   $a1-280-48789-5
010   $a9786613583123
010   $a1-4441-4982-2
024 7 $a10.1201/b13322 
035   $a(CKB)2550000000101751
035   $a(EBL)967157
035   $a(OCoLC)799764130
035   $a(SSID)ssj0000681765
035   $a(PQKBManifestationID)11406736
035   $a(PQKBTitleCode)TC0000681765
035   $a(PQKBWorkID)10663257
035   $a(PQKB)11713799
035   $a(OCoLC)794930564
035   $a(MiAaPQ)EBC967157
035   $a(Au-PeEL)EBL967157
035   $a(CaPaEBR)ebr10563883
035   $a(CaONFJC)MIL358312
035   $a(EXLCZ)992550000000101751
100   $a20180331d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aSarcoidosis /$fDonald N. Mitchell. [et al.]
210  1$aLondon :$cHodder Arnold,$d2012.
215   $a1 online resource (488 p.)
300   $aDescription based upon print version of record.
311   $a0-340-99211-5 
320   $aIncludes bibliographical references and index.
327   $apt. 1. Historical survey, definition and epidemiology -- pt. 2. Etiology, pathology, immunology and genetics -- pt. 3. Investigations -- pt. 4. The heart, pulmonary hypertension, the upper respiratory tract, the airways, and pulmonary fibrosis -- pt. 5. The liver and GI tract, spleen, blood and bone marrow, nervous system, renal and calcium metabolism, and psychiatric aspects -- pt. 6. Skin, eyes, joints and skeletal muscles, superficial lymphadenopathy, and endocrine glands -- pt. 7. Beryllium disease, HIV, and neoplasms -- pt. 8. Childhood sarcoid -- pt. 9. Diagnosis and treatment -- pt. 10. Surgical investigation, management and future research.
330   $aSarcoidosis represents a major challenge for physicians-not just in respiratory medicine, but across a range of specialties. This book, with a multidisciplinary authorship of the highest standard, presents the most up-to-date thinking on all aspects of the condition, from epidemiology to clinical manifestations and treatment options. Full coverage is given to both respiratory and non-respiratory aspects. The basic science that underlies the disease and its progression is evaluated in detail, and placed into its correct clinical context. Possible future advances are covered in a concluding sect
606   $aSarcoidosis
615  0$aSarcoidosis.
676   $a616.429
701   $aMitchell$b Donald$0168023
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910779280203321
996   $aSarcoidosis$93802052
997   $aUNINA